Biopelle®, Inc.

Biopelle, Inc. is a groundbreaking aesthetic company committed to providing high quality, cost-effective skin rejuvenation and wellness products with cutting-edge technologies.

Biopelle was established as the aesthetic division of Ferndale Laboratories, Inc. in August 2005 and incorporated as a subsidiary of the Ferndale Pharma Group, Inc. in April 2007. Charged with the task of developing a unique product portfolio to improve the health and appearance of the skin, Biopelle has developed, licensed, or acquired 10 world class brands which are sold through the offices of medical skin care professionals including dermatologists, medical spas, and plastic surgeons.

Biopelle’s impressive growth in the aesthetic market is a direct result of its dedication in ensuring it delivers value by:

  • helping its customers realize the full aesthetic potential of their patients and clients
  • delivering “a global spectrum of skin care products” represented by its brands
  • funding aesthetic research and education
  • providing exceptional customer service

The brands under the Biopelle umbrella are: L.M.X.4, Auriderm, OC Eight, AFA, Tensage, Ascorderm, Retriderm, PRESCRIBEDsolutions, HELIOCARE, and SYNERGIES, and include periprocedure products, exfoliators, antioxidants, retinoids, growth factors, peptides, moisturizers, skin lighteners, and topical and systemic sun protection modalities.

For more information, visit biopelle.com.